Female, aging, difference formulations of DCI, or lower body weight increases AUC4hr of levodopa in patients with Parkinson's disease
Noriko Nishikawa, Hirotaka Iwaki, Tomotaka Shiraishi, Yohei Mukai, Yuji Takahashi, Miho Murata
Topics & Concepts
BenserazideLevodopaDyskinesiaPharmacokineticsMedicineCmaxCarbidopaParkinson's diseaseAromatic L-amino acid decarboxylaseArea under the curveOral administrationInternal medicineGastroenterologyPharmacologyDiseaseDopamineParkinson's Disease Mechanisms and TreatmentsPharmacology and Obesity TreatmentMedication Adherence and Compliance